Cargando…
Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria
Reactive multi-target ‘fragment drugs’ represent critical components of current tuberculosis regimens. These compounds, such as pyrazinamide, are old synthetic antimycobacterials that are activated inside Mycobacterium tuberculosis bacilli and are smaller than the usual drug-like, single-target mole...
Autores principales: | Moreira, Wilfried, Lim, Jia Jie, Yeo, Si Ying, Ramanujulu, Pondy M., Dymock, Brian W., Dick, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013068/ https://www.ncbi.nlm.nih.gov/pubmed/27656168 http://dx.doi.org/10.3389/fmicb.2016.01392 |
Ejemplares similares
-
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
por: Low, Jian Liang, et al.
Publicado: (2017) -
Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis
por: Hatherill, Mark, et al.
Publicado: (2006) -
Cobalamin is present in cells of non-tuberculous mycobacteria, but not in Mycobacterium tuberculosis
por: Minias, Alina, et al.
Publicado: (2021) -
Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria
por: Solanki, Priya, et al.
Publicado: (2022) -
Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
por: Moreira, Wilfried, et al.
Publicado: (2015)